Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Inmune Bio, Inc. (INMB)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -272.3% | -516.8% | -1013.1% | -3380.4% | -18259.3% | |
ROIC (including intangibles) | -96.6% | -106.2% | -63.2% | -45.3% | -76.0% | -4.9% |
ROE | -43.1% | -33.4% | -29.6% | -32.9% | -75.2% | -4.6% |
ROA | -31.7% | -26.8% | -28.3% | -31.7% | -71.6% | -4.5% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | | |
Cash conversion cycle | | 0.0 | 0.0 | | | |
|